SHBG AND IBP4 ANTIBODIES AND METHODS USING SAME

Sequence-defined anti-SHBG and anti-IBP4 antibodies or antigen-binding fragments thereof are described. The antibodies are comprise heavy chain variable and light chain variable domains, each having sequence-specified complementarity determining regions (CDRs). Also described are nucleic acids encod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GASSMAN, Andrew, PELTIER, John, BONIFACE, John, FLICK, Jeffrey
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sequence-defined anti-SHBG and anti-IBP4 antibodies or antigen-binding fragments thereof are described. The antibodies are comprise heavy chain variable and light chain variable domains, each having sequence-specified complementarity determining regions (CDRs). Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies and sequence-defined epitopes of the antibodies. L'invention concerne des anticorps anti-SHBG et anti-IBP4 ou des fragments de liaison à l'antigène de ceux-ci. L'invention concerne également des acides nucléiques codant les anticorps, des compositions comprenant les anticorps, des procédés de production des anticorps, et des procédés d'utilisation des anticorps.